These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2851034

  • 1. Biological activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cells.
    Soma G, Tsuji Y, Tanabe Y, Noguchi K, Kitahara-Tanabe N, Gatanaga T, Inagawa H, Kawakami M, Mizuno D.
    J Biol Response Mod; 1988 Dec; 7(6):587-95. PubMed ID: 2851034
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T, Noguchi K, Tanabe Y, Inagawa H, Soma G, Mizuno D.
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [Abstract] [Full Text] [Related]

  • 3. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H, Oshima H, Soma G, Mizuno D.
    J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
    Nishigaki F, Miyayasu K, Tsujimoto S, Manda T, Shimomura K.
    Anticancer Res; 1994 Dec; 14(6B):2573-6. PubMed ID: 7872683
    [Abstract] [Full Text] [Related]

  • 6. Intravesical RTNF therapy of superficial bladder cancer. A phase I study of recombinant tumor necrosis factor administered intravesically to patients with superficial bladder cancer.
    Grampsas SA, Kahn K, Crawford ED.
    Online J Curr Clin Trials; 1994 Mar 03; Doc No 117():[4845 words; 36 paragraphs]. PubMed ID: 8136939
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T, Shimomura K, Mukumoto S, Kobayashi K, Mizota T, Hirai O, Matsumoto S, Oku T, Nishigaki F, Mori J.
    Cancer Res; 1987 Jul 15; 47(14):3707-11. PubMed ID: 3594435
    [Abstract] [Full Text] [Related]

  • 8. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 9. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.
    Ruggiero V, Latham K, Baglioni C.
    J Immunol; 1987 Apr 15; 138(8):2711-7. PubMed ID: 3031163
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
    Noguchi K, Inagawa H, Tsuji Y, Morikawa A, Mizuno D, Soma G.
    J Immunother (1991); 1991 Apr 15; 10(2):105-11. PubMed ID: 2043590
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short-term suspension cultures in vitro.
    Beran M, O'Brien S, Gutterman JU, McCredie KB.
    Hematol Pathol; 1988 Apr 15; 2(1):31-42. PubMed ID: 3266210
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma.
    Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Vanderveken J, Schmitz P.
    J Cell Biochem; 1994 Sep 15; 56(1):52-61. PubMed ID: 7806592
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M, O'Brien S, Andersson B, McCredie KB, Gutterman JU.
    Hematol Pathol; 1988 Sep 15; 2(2):65-71. PubMed ID: 3143710
    [Abstract] [Full Text] [Related]

  • 20. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).
    Kashiwa H, Wright SC, Bonavida B.
    J Immunol; 1987 Mar 01; 138(5):1383-90. PubMed ID: 2949015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.